EKF Diagnostics Holdings Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	51.56	50.19	52.61	66.64	81.84
Revenue Growth (YoY)	2.73%	-4.59%	-21.05%	-18.57%	25.40%
Cost of Revenue	25.08	25.8	28.18	35.82	42.47
Gross Profit	26.48	24.4	24.44	30.81	39.37
Selling, General & Admin	19.73	13.82	14.13	16.42	11.26
Research & Development	-	1.35	1.82	1.52	1.38
Amortization of Goodwill & Intangibles	-	1.04	2.07	3.5	3.79
Other Operating Expenses	-0.23	-0.29	-0.16	-0.92	-0.09
Operating Expenses	19.5	17.78	19.52	22.26	17.52
Operating Income	6.98	6.61	4.91	8.55	21.84
Interest Expense	-0.15	-0.17	-0.08	-0.1	-0.07
Interest & Investment Income	0.26	0.17	0.13	0.13	0.05
Other Non Operating Income (Expenses)	-	-	-	-	-0.29
EBT Excluding Unusual Items	7.09	6.62	4.96	8.58	21.53
Merger & Restructuring Charges	-	-0.35	-2.83	-17.53	-0.2
Other Unusual Items	-	-	-	0	0.11
Pretax Income	7.09	6.26	2.13	-8.94	21.44
Income Tax Expense	4.56	-0.31	-0.6	0.63	5.28
Earnings From Continuing Operations	2.53	6.58	2.73	-9.58	16.16
Net Income to Company	2.53	6.58	2.73	-9.58	16.16
Minority Interest in Earnings	-0.41	-0.34	-0.38	-0.53	-0.31
Net Income	2.12	6.24	2.35	-10.1	15.85
Net Income to Common	2.12	6.24	2.35	-10.1	15.85
Net Income Growth	-66.00%	165.39%	-	-	42.62%
Shares Outstanding (Basic)	448	454	454	457	457
Shares Outstanding (Diluted)	448	454	454	457	461
Shares Change (YoY)	-1.19%	-0.08%	-0.67%	-0.82%	0.47%
EPS (Basic)	0.00	0.01	0.01	-0.02	0.03
EPS (Diluted)	0.00	0.01	0.01	-0.02	0.03
EPS Growth	-65.84%	165.63%	-	-	42.16%
Free Cash Flow	8.18	11.41	-0.29	5.25	5.9
Free Cash Flow Per Share	0.02	0.03	-0.00	0.01	0.01
Dividend Per Share	-	-	0.012	0.012	0.012
Dividend Growth	-	-	-	-	9.09%
Gross Margin	51.35%	48.60%	46.45%	46.24%	48.10%
Operating Margin	13.53%	13.17%	9.34%	12.84%	26.69%
Profit Margin	4.12%	12.44%	4.47%	-15.16%	19.37%
Free Cash Flow Margin	15.86%	22.73%	-0.55%	7.89%	7.21%
EBITDA	10.16	10.25	9.25	13.16	26.46
EBITDA Margin	19.70%	20.41%	17.59%	19.75%	32.33%
D&A For EBITDA	3.18	3.64	4.34	4.61	4.62
EBIT	6.98	6.61	4.91	8.55	21.84
EBIT Margin	13.53%	13.17%	9.34%	12.84%	26.69%
Effective Tax Rate	64.28%	-	-	-	24.62%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.